Risk Factors And Outcomes Of Hospital Acquired AKI
- Conditions
- AKI - Acute Kidney Injury
- Interventions
- Other: standard care for hospitalized patientsOther: standard AKI care bundle
- Registration Number
- NCT06051708
- Lead Sponsor
- Alexandria University
- Brief Summary
The aim of the study is to assess the common risk factors for development of hospital acquired acute kidney injury among hospitalized patients in Alexandria Main University hospital and their outcomes.
- Detailed Description
Hospital-acquired AKI (HAAKI) is defined as acute renal insult occurring 48 hours or more after admission to a health care facility and It is estimated to occur in 13-18% of hospitalized patients. The early diagnosis of HAAKI reflects on improvement in morbidity and mortality rates especially in developing countries which goes parallel with the goal The International Society of Nephrology (ISN) to eliminate preventable or treatable deaths from AKI by 2025, the "0 by 25" initiative.
Data concerning the spectrum of acute kidney injury (AKI) in Egypt are generally scarce.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 160
- Fulfilment of definition of acute kidney injury according to KDIGO reference.
- Age more than 18 years.
- Mentally or physically unfit patients.
- Patients who developed acute kidney injury within 48 hours of admission to hospital.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description no AKI group standard care for hospitalized patients patients who are hospitalized and do not develop acute kidney injury after 48 hours from admission till discharge AKI group standard AKI care bundle patients who are hospitalized and develop acute kidney injury after 48 hours from admission
- Primary Outcome Measures
Name Time Method Recovery of kidney functions 12 weeks (improvement of eGFR, serum creatinine to normal or previous baseline).
- Secondary Outcome Measures
Name Time Method Need for renal replacement therapy 12 weeks different modalities of RRT
mortality 12 weeks death
progression to chronic kidney disease. 12 weeks deterioration of kidney functions ( creatinine, eGFR)
Trial Locations
- Locations (1)
Faculty of Medicine, Aexandria University
🇪🇬Alexandria, Egypt